Falsely Low Results Lead FDA To Affix Class I Designation To Recall Of Magellan Lead Tests
Executive Summary
The LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests made by Magellan Diagnostics Inc. were recalled because falsely low results could cause health risks to children and pregnant people.
You may also be interested in...
Recall Of Magellan Lead Tests Just Keeps Getting Bigger And Bigger
It’s the third expansion for a high-risk class I recall of LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests.
Magellan Lead Test Recall Expanded After First Attempted Fix Found Insufficient
Several additional batches of Magellan’s LeadCare II tests are being recalled as efforts to address the root cause continue.
US FDA, CDC Warn Of False Results On Lead Blood Tests
Common blood tests for lead poisoning manufactured by Magellan Diagnostics could give false low results if used with venous blood, FDA warned. About 8 million of the tests have been performed since 2014.